| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations
|
Kleibl, Zdenek
|
|
2007
|
112 |
1 |
p. 159-164
|
artikel
|
| 2 |
Are all aromatase inhibitors alike?
|
Blackwell, Kimberly L.
|
|
2008
|
112 |
1 |
p. 35-43
|
artikel
|
| 3 |
Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling
|
Normanno, Nicola
|
|
2007
|
112 |
1 |
p. 25-33
|
artikel
|
| 4 |
Breast cancer recurrence risk in relation to antidepressant use after diagnosis
|
Chubak, Jessica
|
|
2007
|
112 |
1 |
p. 123-132
|
artikel
|
| 5 |
Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density
|
Verheus, Martijn
|
|
2007
|
112 |
1 |
p. 109-122
|
artikel
|
| 6 |
Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors
|
Wayne, Sharon J.
|
|
2007
|
112 |
1 |
p. 149-158
|
artikel
|
| 7 |
Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan
|
Kondo, Masahide
|
|
2007
|
112 |
1 |
p. 175-187
|
artikel
|
| 8 |
Editorial
|
Aapro, Matti
|
|
2008
|
112 |
1 |
p. 1-3
|
artikel
|
| 9 |
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)
|
Mlineritsch, Brigitte
|
|
2007
|
112 |
1 |
p. 203-213
|
artikel
|
| 10 |
Extending the benefits of adjuvant therapy in early HR+ breast cancer
|
Goss, Paul E.
|
|
2008
|
112 |
1 |
p. 45-52
|
artikel
|
| 11 |
How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature
|
Minton, O.
|
|
2007
|
112 |
1 |
p. 5-13
|
artikel
|
| 12 |
Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family
|
Palanca Suela, Sarai
|
|
2007
|
112 |
1 |
p. 63-67
|
artikel
|
| 13 |
Improving decision-making in early breast cancer: who to treat and how?
|
Llombart-Cussac, Antonio
|
|
2008
|
112 |
1 |
p. 15-24
|
artikel
|
| 14 |
Inactivation of NF-κB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells
|
Domingo-Domènech, Josep
|
|
2007
|
112 |
1 |
p. 53-62
|
artikel
|
| 15 |
In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients
|
Licznerska, Barbara E.
|
|
2007
|
112 |
1 |
p. 15-23
|
artikel
|
| 16 |
Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN)
|
Butler, Lesley M.
|
|
2007
|
112 |
1 |
p. 165-174
|
artikel
|
| 17 |
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
|
Ruckhäberle, Eugen
|
|
2007
|
112 |
1 |
p. 41-52
|
artikel
|
| 18 |
Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients
|
Lo, An-Chi
|
|
2007
|
112 |
1 |
p. 141-147
|
artikel
|
| 19 |
NBS1 variant I171V and breast cancer risk
|
Bogdanova, Natalia
|
|
2007
|
112 |
1 |
p. 75-79
|
artikel
|
| 20 |
Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density
|
Maskarinec, Gertraud
|
|
2007
|
112 |
1 |
p. 133-139
|
artikel
|
| 21 |
Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer
|
Gligorov, Joseph
|
|
2008
|
112 |
1 |
p. 53-66
|
artikel
|
| 22 |
Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer
|
Chlebowski, Rowan T.
|
|
2008
|
112 |
1 |
p. 25-34
|
artikel
|
| 23 |
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer
|
Hoogendoorn, Wilhelmina E.
|
|
2007
|
112 |
1 |
p. 99-108
|
artikel
|
| 24 |
Prognostic factors in long-term breast cancer survivors with brain metastases
|
Harputluoglu, Hakan
|
|
2007
|
112 |
1 |
p. 215
|
artikel
|
| 25 |
Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer
|
Arnedos, Monica
|
|
2007
|
112 |
1 |
p. 1-4
|
artikel
|
| 26 |
Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy
|
Ko, Eunyoung
|
|
2007
|
112 |
1 |
p. 189-195
|
artikel
|
| 27 |
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients
|
Fasching, Peter Andreas
|
|
2007
|
112 |
1 |
p. 89-98
|
artikel
|
| 28 |
TGFβ1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFβ1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy
|
Rajkumar, Thangarajan
|
|
2007
|
112 |
1 |
p. 81-87
|
artikel
|
| 29 |
The RAD51D E233G variant and breast cancer risk: population-based and clinic-based family studies of Australian women
|
Dowty, James G.
|
|
2007
|
112 |
1 |
p. 35-39
|
artikel
|
| 30 |
Treatment decision-making in breast cancer: the patient–doctor relationship
|
Fallowfield, L. J.
|
|
2008
|
112 |
1 |
p. 5-13
|
artikel
|
| 31 |
Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy
|
Navari, Rudolph M.
|
|
2007
|
112 |
1 |
p. 197-201
|
artikel
|
| 32 |
Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain
|
Esteban Cardeñosa, Eva
|
|
2007
|
112 |
1 |
p. 69-73
|
artikel
|
Tijdschrift beschrijving